
The global Soluble Ocular Insert market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Soluble Ocular Insert 91ÖÆÆ¬³§.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Soluble Ocular Insert market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novartis
Bausch + Lomb
Ocular Therapeutix
EyeGate
Bausch Health
Taiwan Liposome
Graybug Vision
Clearside Biomedical
Alimera Sciences
Envisia Therapeutics
Allergan
Segment by Type
Based on Natural Polymers
Based on Synthetic or Semi-synthetic Polymers
Segment by Application
Hospitals and Clinics
Ambulatory Surgery Center
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Soluble Ocular Insert report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Soluble Ocular Insert Market Overview
1.1 Product Overview and Scope of Soluble Ocular Insert
1.2 Soluble Ocular Insert Segment by Type
1.2.1 Global Soluble Ocular Insert Market Value Comparison by Type (2023-2029)
1.2.2 Based on Natural Polymers
1.2.3 Based on Synthetic or Semi-synthetic Polymers
1.3 Soluble Ocular Insert Segment by Application
1.3.1 Global Soluble Ocular Insert Market Value by Application: (2023-2029)
1.3.2 Hospitals and Clinics
1.3.3 Ambulatory Surgery Center
1.3.4 Others
1.4 Global Soluble Ocular Insert Market Size Estimates and Forecasts
1.4.1 Global Soluble Ocular Insert Revenue 2018-2029
1.4.2 Global Soluble Ocular Insert Sales 2018-2029
1.4.3 Global Soluble Ocular Insert Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Soluble Ocular Insert Market Competition by Manufacturers
2.1 Global Soluble Ocular Insert Sales Market Share by Manufacturers (2018-2023)
2.2 Global Soluble Ocular Insert Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Soluble Ocular Insert Average Price by Manufacturers (2018-2023)
2.4 Global Soluble Ocular Insert Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Soluble Ocular Insert, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Soluble Ocular Insert, Product Type & Application
2.7 Soluble Ocular Insert Market Competitive Situation and Trends
2.7.1 Soluble Ocular Insert Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Soluble Ocular Insert Players Market Share by Revenue
2.7.3 Global Soluble Ocular Insert Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Soluble Ocular Insert Retrospective Market Scenario by Region
3.1 Global Soluble Ocular Insert Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Soluble Ocular Insert Global Soluble Ocular Insert Sales by Region: 2018-2029
3.2.1 Global Soluble Ocular Insert Sales by Region: 2018-2023
3.2.2 Global Soluble Ocular Insert Sales by Region: 2024-2029
3.3 Global Soluble Ocular Insert Global Soluble Ocular Insert Revenue by Region: 2018-2029
3.3.1 Global Soluble Ocular Insert Revenue by Region: 2018-2023
3.3.2 Global Soluble Ocular Insert Revenue by Region: 2024-2029
3.4 North America Soluble Ocular Insert Market Facts & Figures by Country
3.4.1 North America Soluble Ocular Insert Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Soluble Ocular Insert Sales by Country (2018-2029)
3.4.3 North America Soluble Ocular Insert Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Soluble Ocular Insert Market Facts & Figures by Country
3.5.1 Europe Soluble Ocular Insert Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Soluble Ocular Insert Sales by Country (2018-2029)
3.5.3 Europe Soluble Ocular Insert Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Soluble Ocular Insert Market Facts & Figures by Country
3.6.1 Asia Pacific Soluble Ocular Insert Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Soluble Ocular Insert Sales by Country (2018-2029)
3.6.3 Asia Pacific Soluble Ocular Insert Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Soluble Ocular Insert Market Facts & Figures by Country
3.7.1 Latin America Soluble Ocular Insert Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Soluble Ocular Insert Sales by Country (2018-2029)
3.7.3 Latin America Soluble Ocular Insert Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Soluble Ocular Insert Market Facts & Figures by Country
3.8.1 Middle East and Africa Soluble Ocular Insert Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Soluble Ocular Insert Sales by Country (2018-2029)
3.8.3 Middle East and Africa Soluble Ocular Insert Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Soluble Ocular Insert Sales by Type (2018-2029)
4.1.1 Global Soluble Ocular Insert Sales by Type (2018-2023)
4.1.2 Global Soluble Ocular Insert Sales by Type (2024-2029)
4.1.3 Global Soluble Ocular Insert Sales Market Share by Type (2018-2029)
4.2 Global Soluble Ocular Insert Revenue by Type (2018-2029)
4.2.1 Global Soluble Ocular Insert Revenue by Type (2018-2023)
4.2.2 Global Soluble Ocular Insert Revenue by Type (2024-2029)
4.2.3 Global Soluble Ocular Insert Revenue Market Share by Type (2018-2029)
4.3 Global Soluble Ocular Insert Price by Type (2018-2029)
5 Segment by Application
5.1 Global Soluble Ocular Insert Sales by Application (2018-2029)
5.1.1 Global Soluble Ocular Insert Sales by Application (2018-2023)
5.1.2 Global Soluble Ocular Insert Sales by Application (2024-2029)
5.1.3 Global Soluble Ocular Insert Sales Market Share by Application (2018-2029)
5.2 Global Soluble Ocular Insert Revenue by Application (2018-2029)
5.2.1 Global Soluble Ocular Insert Revenue by Application (2018-2023)
5.2.2 Global Soluble Ocular Insert Revenue by Application (2024-2029)
5.2.3 Global Soluble Ocular Insert Revenue Market Share by Application (2018-2029)
5.3 Global Soluble Ocular Insert Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Soluble Ocular Insert Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novartis Soluble Ocular Insert Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Bausch + Lomb
6.2.1 Bausch + Lomb Corporation Information
6.2.2 Bausch + Lomb Description and Business Overview
6.2.3 Bausch + Lomb Soluble Ocular Insert Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bausch + Lomb Soluble Ocular Insert Product Portfolio
6.2.5 Bausch + Lomb Recent Developments/Updates
6.3 Ocular Therapeutix
6.3.1 Ocular Therapeutix Corporation Information
6.3.2 Ocular Therapeutix Description and Business Overview
6.3.3 Ocular Therapeutix Soluble Ocular Insert Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ocular Therapeutix Soluble Ocular Insert Product Portfolio
6.3.5 Ocular Therapeutix Recent Developments/Updates
6.4 EyeGate
6.4.1 EyeGate Corporation Information
6.4.2 EyeGate Description and Business Overview
6.4.3 EyeGate Soluble Ocular Insert Sales, Revenue and Gross Margin (2018-2023)
6.4.4 EyeGate Soluble Ocular Insert Product Portfolio
6.4.5 EyeGate Recent Developments/Updates
6.5 Bausch Health
6.5.1 Bausch Health Corporation Information
6.5.2 Bausch Health Description and Business Overview
6.5.3 Bausch Health Soluble Ocular Insert Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bausch Health Soluble Ocular Insert Product Portfolio
6.5.5 Bausch Health Recent Developments/Updates
6.6 Taiwan Liposome
6.6.1 Taiwan Liposome Corporation Information
6.6.2 Taiwan Liposome Description and Business Overview
6.6.3 Taiwan Liposome Soluble Ocular Insert Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Taiwan Liposome Soluble Ocular Insert Product Portfolio
6.6.5 Taiwan Liposome Recent Developments/Updates
6.7 Graybug Vision
6.6.1 Graybug Vision Corporation Information
6.6.2 Graybug Vision Description and Business Overview
6.6.3 Graybug Vision Soluble Ocular Insert Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Graybug Vision Soluble Ocular Insert Product Portfolio
6.7.5 Graybug Vision Recent Developments/Updates
6.8 Clearside Biomedical
6.8.1 Clearside Biomedical Corporation Information
6.8.2 Clearside Biomedical Description and Business Overview
6.8.3 Clearside Biomedical Soluble Ocular Insert Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Clearside Biomedical Soluble Ocular Insert Product Portfolio
6.8.5 Clearside Biomedical Recent Developments/Updates
6.9 Alimera Sciences
6.9.1 Alimera Sciences Corporation Information
6.9.2 Alimera Sciences Description and Business Overview
6.9.3 Alimera Sciences Soluble Ocular Insert Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Alimera Sciences Soluble Ocular Insert Product Portfolio
6.9.5 Alimera Sciences Recent Developments/Updates
6.10 Envisia Therapeutics
6.10.1 Envisia Therapeutics Corporation Information
6.10.2 Envisia Therapeutics Description and Business Overview
6.10.3 Envisia Therapeutics Soluble Ocular Insert Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Envisia Therapeutics Soluble Ocular Insert Product Portfolio
6.10.5 Envisia Therapeutics Recent Developments/Updates
6.11 Allergan
6.11.1 Allergan Corporation Information
6.11.2 Allergan Soluble Ocular Insert Description and Business Overview
6.11.3 Allergan Soluble Ocular Insert Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Allergan Soluble Ocular Insert Product Portfolio
6.11.5 Allergan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Soluble Ocular Insert Industry Chain Analysis
7.2 Soluble Ocular Insert Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Soluble Ocular Insert Production Mode & Process
7.4 Soluble Ocular Insert Sales and Marketing
7.4.1 Soluble Ocular Insert Sales Channels
7.4.2 Soluble Ocular Insert Distributors
7.5 Soluble Ocular Insert Customers
8 Soluble Ocular Insert Market Dynamics
8.1 Soluble Ocular Insert Industry Trends
8.2 Soluble Ocular Insert Market Drivers
8.3 Soluble Ocular Insert Market Challenges
8.4 Soluble Ocular Insert Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Novartis
Bausch + Lomb
Ocular Therapeutix
EyeGate
Bausch Health
Taiwan Liposome
Graybug Vision
Clearside Biomedical
Alimera Sciences
Envisia Therapeutics
Allergan
Ìý
Ìý
*If Applicable.
